This inventor holds 2 USPTO granted patents. Top assignee: Sumitomo Pharmaceuticals Company Limited. Active years: 2001-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2002
Title: Masashi Tanaka: Innovator in Pyridone Derivatives
Introduction
Masashi Tanaka is a notable inventor based in Takaishi, Japan. He has made significant contributions to the field of chemistry, particularly in the development of pyridone derivatives. With a total of 2 patents to his name, Tanaka's work has implications for various applications in pharmaceuticals.
Latest Patents
Tanaka's latest patents include innovative processes for preparing pyridone derivatives. One of his key patents details a method for the preparation of pyridone derivatives using phthalimido-containing starting materials. This process involves reacting a specific compound with a hypochlorite or hypobromite, or with lead tetraacetate, to yield another compound. The subsequent reaction with an additional compound further refines the process. This method is particularly noted for its safety considerations, making it a valuable contribution to the field.
Career Highlights
Masashi Tanaka is currently associated with Sumitomo Pharmaceuticals Company Limited, where he continues to advance his research and development efforts. His work has not only contributed to the company's portfolio but has also enhanced the understanding of pyridone chemistry in the broader scientific community.
Collaborations
Tanaka has collaborated with esteemed colleagues such as Naohito Ohashi and Masami Muraoka. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Masashi Tanaka's contributions to the field of pyridone derivatives exemplify the impact of dedicated research and innovation. His patents reflect a commitment to safety and efficacy in chemical processes, marking him as a significant figure in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile